These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 32339331

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. How I treat my inflammatory bowel disease-patients with thiopurines?
    Meijer B, Mulder CJ, van Bodegraven AA, de Boer NK.
    World J Gastrointest Pharmacol Ther; 2016 Nov 06; 7(4):524-530. PubMed ID: 27867685
    [Abstract] [Full Text] [Related]

  • 23. Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.
    Czaja AJ.
    Aliment Pharmacol Ther; 2020 Jun 06; 51(12):1286-1304. PubMed ID: 32363674
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1269-76. PubMed ID: 15191508
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.
    Meijer B, Mulder CJ, Peters GJ, van Bodegraven AA, de Boer NK.
    World J Gastroenterol; 2016 Oct 28; 22(40):9012-9021. PubMed ID: 27833392
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.
    Seinen ML, van Asseldonk DP, Mulder CJ, de Boer NK.
    J Gastrointestin Liver Dis; 2010 Sep 28; 19(3):291-4. PubMed ID: 20922194
    [Abstract] [Full Text] [Related]

  • 31. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP, Bierau J, Derijks LJ, Bos LP, Hooymans PM, van Gennip A, Stockbrügger RW, Engels LG.
    Aliment Pharmacol Ther; 2005 Oct 01; 22(7):605-11. PubMed ID: 16181300
    [Abstract] [Full Text] [Related]

  • 32. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts.
    Jharap B, Seinen ML, de Boer NK, van Ginkel JR, Linskens RK, Kneppelhout JC, Mulder CJ, van Bodegraven AA.
    Inflamm Bowel Dis; 2010 Sep 01; 16(9):1541-9. PubMed ID: 20155846
    [Abstract] [Full Text] [Related]

  • 33. Low-dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines.
    Eqbal A, Martin A, Doecke JD, Patrick D.
    Intern Med J; 2023 Apr 01; 53(4):559-567. PubMed ID: 34874611
    [Abstract] [Full Text] [Related]

  • 34. The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.
    Friedman AB, Sparrow MP, Gibson PR.
    Int J Rheum Dis; 2014 Feb 01; 17(2):132-41. PubMed ID: 24618304
    [Abstract] [Full Text] [Related]

  • 35. Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide.
    Crouwel F, Simsek M, Mulder CJ, Buiter HJ, De Boer NK.
    J Gastrointestin Liver Dis; 2020 Dec 13; 29(4):637-645. PubMed ID: 33331335
    [Abstract] [Full Text] [Related]

  • 36. The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.
    Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L, CESAME Study Group.
    Aliment Pharmacol Ther; 2017 Feb 13; 45(4):533-541. PubMed ID: 27995656
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased risk of thiopurine-related adverse events in elderly patients with IBD.
    Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E, ENEIDA registry of GETECCU.
    Aliment Pharmacol Ther; 2019 Oct 13; 50(7):780-788. PubMed ID: 31429097
    [Abstract] [Full Text] [Related]

  • 40. Toxicity profile of thiopurines in inflammatory bowel disease: a retrospective cohort analysis.
    Labidi A, Hafi M, Ben Mustapha N, Serghini M, Fekih M, Boubaker J.
    Tunis Med; 2020 May 13; 98(5):404-412. PubMed ID: 32548844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.